菲布罗动物保健

最新新闻

• Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, Vs. FactSet Est of $381.2M
  MT Newswires · 2026/8/27
• 评级变动
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $27
  \u5e02\u573a\u8d44\u8baf · 2025/8/29
• 评级变动
  Morgan Stanley Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2025/11/8
• 评级变动
  J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/12
• J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Announces Target Price $58
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $32
  \u5e02\u573a\u8d44\u8baf · 2026/1/30
• 评级变动
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/2/5
• J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Cuts Target Price to $55
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $62
  \u5e02\u573a\u8d44\u8baf · 2026/4/16
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
  TipRanks · 2026/7/28
• 评级变动
  J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $58
  \u5e02\u573a\u8d44\u8baf · 2026/2/9
• 评级变动
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2025/8/29
• 评级变动
  J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2025/11/7
• 评级变动
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $38
  \u5e02\u573a\u8d44\u8baf · 2026/2/6
• 评级变动
  Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $44
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• Form 144 | Phibro Animal Health(PAHC.US) 10% Stockholder Proposes to Sell 12.36 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  J.P. Morgan Reaffirms Their Buy Rating on Phibro Animal Health (PAHC)
  TipRanks · 2025/9/1
• 评级变动
  Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Cuts Target Price to $44
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  Citi Initiates Phibro Animal Health(PAHC.US) With Hold Rating, Announces Target Price $62
  \u5e02\u573a\u8d44\u8baf · 2026/4/15
• BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/28

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。